Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-28

FDA Approved: LO SIMPESSE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved LO SIMPESSE (levonorgestrel and ethinyl estradiol) under an original application for a generic oral contraceptive by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LO SIMPESSE (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for LO SIMPESSE (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)